Your browser doesn't support javascript.
loading
The Role of Translocator Protein TSPO in Hallmarks of Glioblastoma.
Ammer, Laura-Marie; Vollmann-Zwerenz, Arabel; Ruf, Viktoria; Wetzel, Christian H; Riemenschneider, Markus J; Albert, Nathalie L; Beckhove, Philipp; Hau, Peter.
  • Ammer LM; Wilhelm Sander-NeuroOncology Unit and Department of Neurology, University Hospital Regensburg, 93053 Regensburg, Germany.
  • Vollmann-Zwerenz A; Wilhelm Sander-NeuroOncology Unit and Department of Neurology, University Hospital Regensburg, 93053 Regensburg, Germany.
  • Ruf V; Center for Neuropathology and Prion Research, Ludwig Maximilians University of Munich, 81377 Munich, Germany.
  • Wetzel CH; Molecular Neurosciences, Department of Psychiatry and Psychotherapy, University of Regensburg, 93053 Regensburg, Germany.
  • Riemenschneider MJ; Department of Neuropathology, Regensburg University Hospital, 93053 Regensburg, Germany.
  • Albert NL; Department of Nuclear Medicine, Ludwig-Maximilians-University Munich, 81377 Munich, Germany.
  • Beckhove P; Regensburg Center for Interventional Immunology (RCI) and Department Internal Medicine III, University Hospital Regensburg, 93053 Regensburg, Germany.
  • Hau P; Wilhelm Sander-NeuroOncology Unit and Department of Neurology, University Hospital Regensburg, 93053 Regensburg, Germany.
Cancers (Basel) ; 12(10)2020 Oct 14.
Article en En | MEDLINE | ID: mdl-33066460